Healthcare Triangle hit with Nasdaq delisting notice; no cure period after 1-for-14,940 cumulative reverse splits

Healthcare Triangle, Inc.

Nasdaq Staff Delisting Determination dated Oct 1, 2026: HCTI fails the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2).
No 180-day cure period available: 1-for-249 reverse split on Aug 1, 2025 plus 1-for-60 on Feb 10, 2026 equals a cumulative 1-for-14,940 ratio, exceeding the 250-to-1 limit in Rule 5810(c)(3)(A)(iv).
Company must appeal to a Nasdaq Hearings Panel by Oct 8, 2026; otherwise trading is suspended at the open on Oct 12, 2026 and a Form 25-NSE will be filed to delist and deregister the stock.
Healthcare Triangle says it intends to timely request a hearing and present a compliance plan that may include another reverse stock split; no assurance the Panel grants continued listing.
The notice has no immediate effect on trading, and HCTI shares continue to trade on the Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.